XML 21 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)
6 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net Loss $ (5,442,414) $ (7,285,662)
Adjustments to reconcile Net Loss to Net Cash used by operations:    
Depreciation and amortization 2,364,836 2,242,048
Debt discount amortization 219,333 24,144
Employee stock awards 475,736 506,500
Stock grants 147,675 379,694
Stock for services 200,000
Contingent consideration payable fair value (57,358)
Interest on convertible promissory notes 18,226
Allowance for doubtful accounts 23,171 (103,644)
Reduction in right of use asset 205,205
Other (Income)/expense 186,600
Loss on Jagemann Munition Components 1,000,000
Changes in Current Assets and Liabilities    
Accounts receivable (2,349,630) (1,189,573)
Due to (from) related parties 150 (32,376)
Inventories (3,194,958) (256,614)
Prepaid expenses 35,334 122,349
Deposits (61,230) (3,960)
Accounts payable 1,916,013 2,337,445
Accrued liabilities 1,145,451 60,788
Operating lease liability (203,472)
Net cash used in operating activities (3,750,758) (2,980,635)
Cash flows from investing activities:    
Purchase of equipment (2,275,466) (426,467)
Net cash used in investing activities (2,275,466) (426,467)
Cash flow from financing activities:    
Proceeds from inventory facility 2,250,000
Proceeds from factoring liability 15,289,000
Payments on factoring liability (15,220,358) 1,036,273
Proceeds from paycheck protection program notes 1,051,985
Proceeds from note payable related party issued 3,500,000 375,000
Payments on note payable - related party (1,099,030) (1,500,000)
Payments on insurance premium note payment (270,233) (201,238)
Sale of common stock 2,881,871 2,465,540
Common stock issued for exercised warrants 242,425
Common stock issuance costs (70,000) (285,981)
Contingent consideration payment (150,000)
Net cash provided by financing activities 8,555,660 1,739,594
Net increase/(decrease) in cash 2,529,436 (1,667,508)
Cash, beginning of period 884,274 2,181,246
Cash, end of period 3,413,710 513,738
Supplemental cash flow disclosures    
Cash paid during the period for - Interest 447,105 346,800
Cash paid during the period for - Income taxes
Non-cash investing and financing activities:    
Accounts payable (2,635,797)
Note payable related party 2,635,797
Right of use assets - operating leases (737,680) (4,288,208)
Operating lease liability 737,680 4,288,208
Insurance premium note payment 226,539 165,120
Prepaid expenses (226,539) (165,120)
Convertible promissory note (300,000)
Convertible promissory note conversion 300,000
Total non-cash investing and financing activities